We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
MY01 Inc. is on a mission to empower healthcare professionals with the ability to pre-empt severe medical conditions, improving patient outcomes. MY01 inc. today announced U.S. Food and Drug
Global leader in textile and materials innovation, HeiQ, launches HeiQ MetalliQ, a futuristic-looking, high-tech surgical mask that destroys all viruses and bacteria tested, up to 100% efficacy. HeiQ
The Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard Medical School (HMS) and the Massachusetts-based startup Rhinostics announced today that the University’s sample collection swab and high-throughput automation technologies have been licensed to Rhinostics. The company
FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) and subsidiary FluroTest Diagnostics Systems (“FluroTest” or The Company), a first-mover in surge-scale rapid antigen testing for the detection of SARS-CoV-2 and other pathogens, today announces it has
Cerus Endovascular has secured an approval from the Food and Drug Administration (FDA) to conduct a clinical trial for the Contour Neurovascular System in the US. In February,
Medical technology company ONWARD has raised $32m funding for the development and commercialisation of its ARC Therapy. The financing round was led by Dutch impact investor Invest-NL and
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, has announced the full commercial launch of CNSide™, its cerebrospinal fluid (CSF) assay designed to
InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care
US researchers have developed a new wristwatch-like device to detect a cytokine storm that is considered as one of the most serious symptoms of Covid-19. Researchers at the
Canon Medical Systems USA announced that its Deep Learning Spectral CT has secured 510(k) clearance from the Food and Drug Administration (FDA) for expanded capabilities into cardiovascular applications.